リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「前立腺癌に対する強度変調放射線治療における晩期直腸有害事象の発生予測因子」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

前立腺癌に対する強度変調放射線治療における晩期直腸有害事象の発生予測因子

神事, 優香 深澤, 歩 酒井, 阿裕美 小岩井, 慶一郎 藤永, 康成 信州大学 DOI:10.11441/shinshumedj.71.159

2023.06.13

概要

Purpose : To identify predictive factors for late rectal toxicity in prostate cancer patient who underwent intensitymodulated radiation therapy (IMRT). Methods : 415 prostate cancer patients who underwent IMRT between November 2008 and September 2019 were included. All patients underwent definitive radiation therapy with a total prescribed dose of 78 Gy, and 2 Gy per fraction. We analyzed the relationship between late rectal toxicity and the following factors : National Comprehensive Cancer Network (NCCN) risk classification, use of anticoagulants, radiation methods and various dose-volume histogram parameters. Results : Median follow-up period was 46 months (3-133). Grade ≥ 2 late rectal adverse events occurred in 8.0 % (n=33). Univariate analysis revealed that NCCN high-risk group (P=0.026) and low percentage of bladder wall volume irradictaed 70 Gy or more to total bladder wall volume (BW V70Gy%) were significantly associated with increased rate of Grade ≥ 2 late rectal toxicity (P=0.026 and 0.036, respectively). Multivariate analysis showed that both of them were independently accociated with the rate of the toxicity (P=0.016 and 0.033, respectively). Conclusion : NCCN high-risk group and low BW V70Gy% might be predictive factors for Grade ≥ 2 late rectal toxicity.

参考文献

1) 国立がん研究センター:全国がん登録データ,2019.https://ganjoho.jp/reg-_stat/statistics/stat/summary.html

2)

Kupelian PA, Potters L, Khuntia D, et al : Radical prostatectomy, external beam radiotherapy <72 Gy, external

beam radiotherapy> or=72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for

stage T1-T2 prostate cancer. Int J Radiat Oncol Biol Phys 58 : 25-33, 2004

3) 小塚拓洋:新版前立腺癌放射線治療のすべて.pp 48-56,金原出版,東京,2013

4)

Zelefsky MJ, Chan H, Hunt M, et al : Long-term outcome of high dose intensity modulated radiation therapy of

patients with clinically localized prostate cancer. J Urol 115 : 1415-1419, 2006

5) Zelefsky MJ, Kollmeier M, Cox B, et al : Improved clinical outcomes with high-dose image guided radiotherapy

compared with non-IGRT for the treatment of clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 84 :

125-129, 2012

6)

Maki S, Itoh Y, Kubota S, et al : Late Rectal Toxicity from Image-guided Intensity Modulated Radiotherapy for

Prostate Cancer. Anticancer Res 36 : 2967-2973, 2016

7) Katahira-Suzuki R, Omura M, Takano S, et al : Clinical and dosimetric predictors of late rectal bleeding of prostate

cancer after TomoTherapy intensity modulated radiation therapy. J Med Radiat Sci 64 : 172-179, 2017

8) Chennupati SK, Pelizzari CA, Kunnavakkam R, Liauw SL : Late toxicity and quality of life after definitive treatment

of prostate cancer : redefining optimal rectal sparing constraints for intensity-modulated radiation therapy. Cancer

Med 3 : 954-961, 2014

9)

Fonteyne V, Ost P, Vanpachtenbeke F, et al : Rectal toxicity after intensity modulated radiotherapy for prostate

cancer : which rectal dose volume constraints should we use ? Radiother Oncol 113 : 398-403, 2014

10) Someya M, Hori M, Tateoka K, et al : Results and DVH analysis of late rectal bleeding in patients treated with 3DCRT or IMRT for localized prostate cancer. J Radiat Res 56 : 122-127, 2015

(R 4. 11. 30 受稿;R 5. 1. 31 受理) No. 3, 2023

165

...

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文

一発検索!

この論文の関連論文を見る